Pathomechanisms in channelopathies of skeletal muscle and brain

Annual Review of Neuroscience

Volumn 29, Issue , 2006, Pages 387-415

  Cannon, Stephen C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Epilepsy; Episodic ataxia; Ion channel; Mutation; Myotonia; Periodic paralysis

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CALCIUM CHANNEL; CHLORIDE CHANNEL; GLYCINE RECEPTOR; ION CHANNEL; POTASSIUM CHANNEL; SODIUM CHANNEL;

ATAXIA; AUTOSOMAL DOMINANT INHERITANCE; BRAIN ATROPHY; CELL ACTIVITY; CELL STIMULATION; CHANNEL GATING; DYSKINESIA; FRONTAL LOBE EPILEPSY; GENE MUTATION; GENETIC DISORDER; GLYCOGEN STORAGE DISEASE TYPE 4; HEADACHE; HUMAN; HYPOKALEMIA; MIGRAINE; MUSCLE EXCITATION; MYASTHENIA; MYOTONIA; NEUROMUSCULAR TRANSMISSION; PARALYSIS; PATHOGENESIS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SARCOLEMMA; SEIZURE; SKELETAL MUSCLE; STARTLE EPILEPSY; ANIMAL; BRAIN; BRAIN DISEASE; CHEMICAL STRUCTURE; CYTOLOGY; GENETICS; METABOLISM; MUSCLE DISEASE; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BRAIN; BRAIN DISEASES; HUMANS; ION CHANNELS; MODELS, MOLECULAR; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUTATION;

EID: 33748372269     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.29.051605.112815     Document Type: Review

References (100)

1. Adrian RH, Bryant SH. 1974. On the repetitive discharge in myotonic muscle fibres. J. Physiol. 240:505-15
2. Ashcroft FM. 2000. Ion Channels and Disease. San Diego: Academic
3. Audenaert D, Claes L, Ceulemans B, Lofgren A, Van Broeckhoven C, De Jonghe P. 2003. A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy. Neurology 61:854-56
4. 2-subunit gene. Nat. Genet. 28:46-48
5. A-receptor transmission in transgenic mice. J. Neurosci. 22:2505-12
6. Biervert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, et al. 1998. A potassium channel mutation in neonatal human epilepsy. Science 279:403-6
7. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, et al. 1992. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat located at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799-808
8. Browne DL, Gancher ST, Nutt JG, Brunt ERP, Smith EA, et al. 1994. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat. Genet. 8:136-40
9. Brune W, Weber RG, Saul B, von Knebel Doeberitz M, Grond-Ginsbach C, et al. 1996. A GLRA1 null mutation in recessive hyperekplexia challenges the functional role of glycine receptors. Am. J. Hum. Genet. 58:989-97
10. Cannon SC. 2000. Spectrum of sodium channel disturbances in the nondystrophic myotonias and periodic paralyses. Kidney Int. 57:772-79
11. Cannon SC. 2002. An expanding view for the molecular basis of familial periodic paralysis. Neuromuscul. Disord. 12:533-43
12. Cannon SC, Brown RHJ, Corey DP. 1993. Theoretical reconstruction of myotonia and paralysis caused by incomplete inactivation of sodium channels. Biophys. J. 65:270-88
13. Cannon SC, Strittmatter SM. 1993. Functional expression of sodium channel mutations identified in families with periodic paralysis. Neuron 10:317-26
14. 1 subunit reduces membrane expression and impairs gating by agonists. J. Biol. Chem. 279:25598-604
15. 1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J. Neurosci. 24:4030-42
16. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. 2001. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet. 68:1327-32
17. Cossette P, Liu L, Brisebois K, Dong H, Lortie A, et al. 2002. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat. Genet. 31:184-89
18. Creutzfeldt OD, Abbott PC, Fowler WM, Pearson CM. 1963. Muscle membrane potentials in episodica adynamia. Electroenceph. Clin. Neurophysiol. 15:508-15
19. + channel mutation causing hyperkalemic periodic paralysis. Neuron 10:667-78
20. 2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33:192-96
21. Deymeer F, Lehmann-Horn F, Serdaroglu P, Cakirkaya S, Benz S, et al. 1999. Electrical myotonia in heterozygous carriers of recessive myotonia congenita. Muscle Nerve 22:123-25
22. Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, et al. 2005. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366:371-77
23. Du W, Bautista JF, Yang H, Diez-Sampedro A, You SA, et al. 2005. Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat. Genet. 37:733-38
24. Dutzler R, Campbell EB, Cadene M, Chait BT, MacKinnon R. 2002. X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature 415:287-94
25. Engel AG, Lambert EH, Mulder DM, Torres CF, Sahashi K, et al. 1982. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann. Neurol. 11:553-69
26. Engel AG, Ohno K, Bouzat C, Sine SM, Griggs RC. 1996. End-plate acetylcholine receptor deficiency due to nonsense mutations in the ε subunit. Ann. Neurol. 40:810-17
27. Engel AG, Ohno K, Sine SM. 2003. Neurological diseases: sleuthing molecular targets for neurological diseases at the neuromuscular junction. Nat. Rev. Neurosci. 4:339-52
28. Fahlke C, Beck CL, George ALJ. 1997. A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel. Proc. Natl. Acad. Sci. USA 94:2729-34
29. Fahlke C, Rüdel R, Mitrovic N, Zhou M, George ALJ. 1995. An aspartic acid residue important for voltage-dependent gating of human muscle chloride channels. Neuron 15:463-72
30. Fonck C, Nashmi R, Deshpande P, Damaj MI, Marks MJ, et al. 2003. Increased sensitivity to agonist-induced seizures, straub tail, and hippocampal theta rhythm in knock-in mice carrying hypersensitive α4 nicotinic receptors. J. Neurosci. 23:2582-90
31. Fontaine B, Khurana TS, Hoffman EP, Bruns GA, Haines JL, et al. 1990. Hyperkalemic periodic paralysis and the adult muscle sodium channel α-subunit gene. Science 250:1000-2
32. Fontaine B, Vale-Santos J, Jurkat-Rott K, Reboul J, Plassart E, et al. 1994. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat. Genet. 6:267-72
33. Furman RE, Barchi RL. 1978. The pathophysiology of myotonia produced by aromatic carboxylic acids. Ann. Neurol. 4:357-65
34. Gomez CM, Maselli RA, Groshong J, Zayas R, Wollmann RL, et al. 2002. Active calcium accumulation underlies severe weakness in a panel of mice with slow-channel syndrome. J. Neurosci. 22:6447-57
35. Guida S, Trettel F, Pagnutti S, Mantuano E, Tottene A, et al. 2001. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am. J. Hum. Genet. 68:759-64
36. Haug K, Warnstedt M, Alekov AK, Sander T, Ramirez A, et al. 2 003. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat. Genet. 33:527-32
37. Hayward LJ, Brown RHJ, Cannon SC. 1996. Inactivation defects caused by myotonia-associated mutations in the sodium channel III-IV linker. J. Gen. Physiol. 107:559-76
38. Hayward LJ, Sandoval GM, Cannon SC. 1999. Defective slow inactivation of sodium channels contributes to familial periodic paralysis. Neurology 52:1447-53
39. Herson PS, Virk M, Rustay NR, Bond CT, Crabbe JC, et al. 2003. A mouse model of episodic ataxia type-1. Nat. Neurosci. 6:378-83
40. Imbrici P, Jaffe SL, Eunson LH, Davies NP, Herd C, et al. 2004. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 127:2682-92
41. Jen J, Kim GW, Baloh RW. 2004. Clinical spectrum of episodic ataxia type 2. Neurology 62:17-22
42. Jen J, Wan J, Graves M, Yu H, Mock AF, et al. 2001. Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Neurology 57:1843-48
43. 1A- subunit. Proc. Natl. Acad. Sci. USA 96:15245-50
44. Jurkat-Rott K, Lehmann-Horn F. 2005. Muscle channelopathies and critical points in functional and genetic studies. J. Clin. Invest. 115:2000-9
45. Jurkat-Rott K, Lehmann-Horn F, Albaz A, Heine R, Gregg RG, et al. 1994. A calcium channel mutation causing hypokalemic periodic paralysis. Hum. Mol. Genet. 3:1415-19
46. Jurkat-Rott K, Mitrovic N, Hang C, Kouzmekine A, Iaizzo P, et al. 2000. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc. Natl. Acad. Sci. USA 97:9549-54
47. 1 subunits (R528H). FEBS Lett. 423:198-204
48. Lapie P, Lory P, Fontaine B. 1997. Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. Neuromuscul. Disord. 7:234-40
49. Lehmann-Horn F, Jurkat-Rott K. 1999. Voltage-gated ion channels and hereditary disease. Physiol. Rev. 79:1317-72
50. Lehmann-Horn F, Rüdel R, Jurkat-Rott K. 2004. Nondystrophic myotonias and periodic paralyses. In Myology, ed. AG Engel, C Franzini-Armstrong, pp. 1257-300. New York: McGraw-Hill
51. Lehmann-Horn F, Rüdel R, Ricker K, Lorkovic H, Dengler R, Hopf HC. 1983, Two cases of adynamia episodica hereditaria: in vitro investigation of muscle cell membrane and contraction parameters. Muscle Nerve 6:113-21
52. Leppert M, Anderson VE, Quattlebaum T, Stauffer D, O'Connell P, et al. 1989. Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 337:647-48
53. Lerche H, Weber YG, Jurkat-Rott K, Lehmann-Horn F. 2005. Ion channel defects in idiopathic epilepsies. Curr. Pharm. Des. 11:2737-52
54. Lewis TB, Leach RJ, Ward K, O'Connell P, Ryan SG. 1993. Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q. Am. J. Hum. Genet. 53:670-75
55. Lipicky RJ, Bryant SH, Salmon JH. 1971. Cable parameters, sodium, potassium, chloride, and water content, and potassium efflux in isolated external intercostal muscle of normal volunteers and patients with myotonia congenita. J. Clin. Invest. 50:2091-103
56. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, et al. 2001. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864-67
57. Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, et al. 2002. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel premRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10:35-44
58. Manto MU. 2005. The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum 4:2-6
59. Matsuyama Z, Kawakami H, Maruyama H, Izumi Y, Komure O, et al. 1997. Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6). Hum. Mol. Genet. 6:1283-87
60. 2+ channel property by polyglutamine expansion in spinocerebellar ataxia 6. J. Neurosci. 19:RC14
61. 2+ channel-loss-of-function cellular model of SCA6. Neurobiol. Dis. 17:198-204
62. Meisler MH, Kearney JA. 2005. Sodium channel mutations in epilepsy and other neurological disorders. J. Clin. Invest. 115:2010-17
63. Mitrovic N, George ALJ, Lerche H, Wagner S, Fahlke C, Lehmann-Horn F. 1995. Different effects on gating of three myotonia-causing mutations in the inactivation gate of the human muscle sodium channel. J. Physiol. 487:107-14
64. 2+ channel expressed in Xenopus laevis oocytes. J. Physiol. 520(Pt. 2):321-36
65. Ohno K, Wang HL, Milone M, Bren N, Brengman JM, et al. 1996. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ε subunit. Neuron 17:157-70
66. 2+ channel gene CACNL1A4. Cell 87:543-52
67. 2+ channel currents arising from expanded trinucleotide repeats in spinocerebellar ataxia type 6. J. Neurosci. 21:9185-93
68. Pietrobon D. 2005. Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr. Opin. Neurobiol. 15:257-65
69. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, et al. 2001. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105:511-19
70. Ptacek LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, et al. 1994. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77:863-68
71. Pusch M. 2002. Myotonia caused by mutations in the muscle chloride channel gene CLCN1. Hum. Mutat. 19:423-34
72. 1 subunit of the inhibitory glycine receptor. Hum. Mol. Genet. 3:2175-79
73. Rees MI, Lewis TM, Kwok JB, Mortier GR, Govaert P, et al. 2002. Hyperekplexia associated with compound heterozygote mutations in the β-subunit of the human inhibitory glycine receptor (GLRB). Hum. Mol. Genet. 11:853-60
74. Restituito S, Thompson RM, Eliet J, Raike RS, Riedl M, et al. 2000. The polyglutamine expansion in spinocerebellar ataxia type 6 causes a β subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes. J. Neurosci. 20:6394-403
75. Rhodes TH, Lossin C, Vanoye CG, Wang DW, George ALJ. 2004. Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. Proc. Natl. Acad. Sci. USA 101:11147-52
76. Rhodes TH, Vanoye CG, Ohmori I, Ogiwara I, Yamakawa K, George ALJ. 2005. Sodium channel dysfunction in intractable childhood epilepsy with generalized tonic-clonic seizures. J. Physiol. 569:433-45
77. Rüdel R, Lehmann-Horn F, Ricker K, Kuther G. 1984. Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters. Muscle Nerve 7:110-20
78. + current. Neurology 53:1556-63
79. 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat. Genet. 5:351-58
80. Smart SL, Lopantsev V, Zhang CL, Robbins CA, Wang H, et al. 1998. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 20:809-19
81. Steinlein OK. 2004. Genetic mechanisms that underlie epilepsy. Nat. Rev. Neurosci. 5:400-8
82. 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 11:201-3
83. Sternberg D, Maisonobe T, Jurkat-Rott K, Nicole S, Launay E, et al. 2001. Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 124:1091-99
84. Struyk AF, Scoggan KA, Bulman DE, Cannon SC. 2000. The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation. J. Neurosci. 20:8610-17
85. Tawil R, Ptacek LJ, Pavlakis SG, DeVivo DC, Penn AS, et al. 1994. Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann. Neurol. 35:326-30
86. 2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons, Proc. Natl. Acad. Sci. USA 99:13284-89
87. + channels in patients with hypokalemic periodic paralysis. J. Clin. Invest. 103:675-82
88. Tsujino A, Maertens C, Ohno K, Shen XM, Fukuda T, et al. 2003. Myasthenie syndrome caused by mutation of the SCN4A sodium channel. Proc. Natl. Acad. Sci. USA 100:7377-82
89. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, Kaja S, Broos LA, et al. 2004. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41:701-10
90. Vohra BP, Groshong JS, Maselli RA, Verity MA, Wollmann RL, Gomez CM. 2004. Focal caspase activation underlies the endplate myopathy in slow-channel syndrome. Ann. Neurol. 55:347-52
91. 2-subunit in childhood absence epilepsy and febrile seizures. Nat. Genet. 28:49-52
92. 1 subunit gene SCN1B. Nat. Genet. 19:366-70
93. Wang HL, Auerbach A, Bren N, Ohno K, Engel AG, Sine SM. 1997. Mutation in the M1 domain of the acetylcholine receptor α subunit decreases the rate of agonist dissociation. J. Gen. Physiol. 109:757-66
94. Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, et al. 1998. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282:1890-93
95. Wu FF, Ryan A, Devaney J, Warnstedt M, Korade-Mirnics Z, et al. 2002. Novel CLCN1 mutations with unique clinical and electrophysiological consequences. Brain 125:2392-407
96. Yang N, Ji S, Zhou M, Ptacek LJ, Barchi RL, et al. 1994. Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro. Proc. Natl. Acad. Sci. USA 91:12785-89
97. +-mediated vasodilation. Circ. Res. 87:160-66
98. Zerr P, Adelman JP, Maylie J. 1998. Episodic ataxia mutations in Kv1.1 alter potassium channel function by dominant negative effects or haploinsufficiency. J. Neurosci. 18:2842-48
99. 1A-voltage-dependent calcium channel. Nat. Genet. 15:62-69
100. Zuberi SM, Eunson LH, Spauschus A, De Silva R, Tolmie J, et al. 1999. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122:817-25